ACB Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

3.060

Open

3.010

VWAP

2.97

Vol

1.64M

Mkt Cap

180.87M

Low

2.920

Amount

4.85M

EV/EBITDA(TTM)

--

Total Shares

61.94M

EV

144.57M

EV/OCF(TTM)

--

P/S(TTM)

0.74

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company's segments include Cannabis and Plant Propagation. Its adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. The Company's medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others. The Company is engaged in distribution wholesale medical cannabis in various international markets, including Australia, New Zealand, and the Caribbean. It has manufacturing facilities in Canada and Germany.

Show More

Events Timeline

(ET)

2026-06-11

09:30:00

U.S. Futures Rebound, Intel Price Target Raised to $135

2026-06-11

07:30:00

Aurora Reports Q4 Adjusted EBITDA of $9.2M

2026-04-23 (ET)

2026-04-23

13:10:00

Roth Capital: Cannabis Products Rescheduled to Schedule 3

2026-04-23

10:30:00

Trump Orders Medical Marijuana Products to Schedule III

2026-04-23

10:00:00

Trump Signs Order to Reschedule Medical Marijuana to Schedule III

2026-04-22 (ET)

2026-04-22

12:00:00

Trump Administration Expected to Reclassify Cannabis on Wednesday

2026-03-19 (ET)

2026-03-19

11:20:00

Representative Proposes Bill to Protect Legal Cannabis Businesses

2026-03-09 (ET)

2026-03-09

08:50:00

Significant Increases in Indicative Borrow Rates for Liquid Options

2026-03-05 (ET)

2026-03-05

08:50:00

Klarna Group Borrow Rate Increases to 31.14%

News

Yahoo Finance

06-11Yahoo Finance

Aurora Cannabis Reports Strong FY 2026 Earnings Exceeding Guidance

seekingalpha

06-11seekingalpha

Aurora Cannabis Reports Q4 Results with Weak FY27 Outlook

PRnewswire

06-11PRnewswire

Aurora Cannabis Exceeds Fiscal Year 2026 Revenue Expectations

Newsfilter

06-11Newsfilter

Aurora Cannabis Reports Record Revenue and EBITDA for FY2026

seekingalpha

06-11seekingalpha

Aurora Cannabis Q4 Earnings Beat Expectations with Strong Revenue Growth

seekingalpha

06-11seekingalpha

Aurora Cannabis Q4 Earnings Preview Indicates Loss

3 Analyst Rating

Wall Street analysts forecast ACB stock price to rise

3 Buy

0 Hold

0 Sell

Strong Buy

Current: 0.000

Low

6.28

Averages

6.77

High

7.39

Current: 0.000

Low

6.28

Averages

6.77

High

7.39

Canaccord

Buy

downgrade

$10 -> $9

AI Analysis

2026-02-05

Reason

Canaccord

Price Target

$10 -> $9

AI Analysis

2026-02-05

downgrade

Buy

Reason

Canaccord lowered the firm's price target on Aurora Cannabis to C$9 from C$10 and keeps a Buy rating on the shares.

Canaccord

Buy

initiated

$10

2026-01-27

Reason

Canaccord

Price Target

$10

2026-01-27

initiated

Buy

Reason

Canaccord initiated coverage of Aurora Cannabis with a Buy rating and C$10 price target. The medical-first operator is "the leading medical player" in Canada and "a foremost player" in the key international markets of Germany, Poland, Australia, and the UK, the analyst tells investors in a note starting coverage of the the Canadian cannabis group. A domestic pivot supported an expansion into the high-margin international markets, where gross margins are roughly 2.5-times higher, on average, than in Aurora's medically focused Canadian business, the analyst noted.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ACB

Unlock Now

Valuation Metrics

The current forward P/E ratio for Aurora Cannabis Inc (ACB.O) is 19.16, compared to its 5-year average forward P/E of -53.00. For a more detailed relative valuation and DCF analysis to assess Aurora Cannabis Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

-53.00

Current PE

19.16

Overvalued PE

300.13

Undervalued PE

-406.12

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

-2.63

Current EV/EBITDA

4.35

Overvalued EV/EBITDA

40.47

Undervalued EV/EBITDA

-45.73

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

2.20

Current PS

0.57

Overvalued PS

4.33

Undervalued PS

0.07

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

stocks under $5 for day trade today

Intellectia · 112 candidates

Region: USPrice: <= $5.00Volume: >= 1,000,000Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEIs Optionable: TrueMin5 Price Change Pct: >= $0.00

Ticker

Name

Market Cap$

Atossa Therapeutics Inc

37.89M

Smith Micro Software Inc

23.14M

Vera Bradley Inc

98.40M

NOVONIX Ltd

146.58M

Cosmos Health Inc

14.16M

Gaotu Techedu Inc

349.93M

how is cannibis securities doing today

Intellectia · 8 candidates

Market Cap: >= 100.00MPrice: >= $1.00Themes: The Cannabis IndustryMonthly Average Dollar Volume: >= 200,000

Ticker

Name

Market Cap$

Canopy Growth Corp

511.04M

Tilray Brands Inc

803.02M

SNDL Inc

391.39M

Village Farms International Inc

328.97M

Aurora Cannabis Inc

201.89M

Innovative Industrial Properties Inc

1.49B

Should I Buy cannabis stocks?

Intellectia · 9 candidates

Market Cap: >= 50.00MThemes: The Cannabis IndustryList Exchange: XNYS, XNASMonthly Average Dollar Volume: >= 100,000

Ticker

Name

Market Cap$

Scotts Miracle-Gro Co

4.06B

Innovative Industrial Properties Inc

1.29B

Cronos Group Inc

1.01B

Tilray Brands Inc

874.97M

Canopy Growth Corp

440.50M

SNDL Inc

386.25M

what cannabis stocks would you buy?

Intellectia · 4 candidates

Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryQuarter Revenue Yoy Growth: >= 0.0%Monthly Average Dollar Volume: >= 300,000

Ticker

Name

Market Cap$

Cronos Group Inc

1.01B

Tilray Brands Inc

874.97M

SNDL Inc

386.25M

Aurora Cannabis Inc

204.15M

Intellectia · 8 candidates

Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryIs Optionable: TrueMonthly Average Dollar Volume: >= 200,000

Ticker

Name

Market Cap$

Scotts Miracle-Gro Co

4.06B

Innovative Industrial Properties Inc

1.29B

Cronos Group Inc

1.01B

Tilray Brands Inc

874.97M

Canopy Growth Corp

440.50M

SNDL Inc

386.25M

marijuana stocks

Intellectia · 8 candidates

Market Cap: >= 200.00MRegion: US, CanadaPrice: >= $1.00Themes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 300,000

Ticker

Name

Market Cap$

Scotts Miracle-Gro Co

3.70B

Innovative Industrial Properties Inc

1.41B

Tilray Brands Inc

1.01B

Cronos Group Inc

999.35M

Canopy Growth Corp

460.70M

SNDL Inc

406.85M

Top cannabis stocks to buy

Intellectia · 9 candidates

Market Cap: >= 50.00MRevenue Ttm: >= 10.00MThemes: The Cannabis Industry

Ticker

Name

Market Cap$

Scotts Miracle-Gro Co

3.70B

Innovative Industrial Properties Inc

1.41B

Tilray Brands Inc

1.01B

Cronos Group Inc

999.35M

Canopy Growth Corp

460.70M

SNDL Inc

406.85M

Whales Holding ACB

Trading Trends

People Also Watch

Frequently Asked Questions

What is Aurora Cannabis Inc (ACB) stock price today?

The current price of ACB is 2.92 USD — it has decreased -2.67

What is Aurora Cannabis Inc (ACB)'s business?

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company's segments include Cannabis and Plant Propagation. Its adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. The Company's medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others. The Company is engaged in distribution wholesale medical cannabis in various international markets, including Australia, New Zealand, and the Caribbean. It has manufacturing facilities in Canada and Germany.

What is the price predicton of ACB Stock?

Wall Street analysts forecast ACB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACB is6.77 USD with a low forecast of 6.28 USD and a high forecast of 7.39 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Aurora Cannabis Inc (ACB)'s revenue for the last quarter?

Aurora Cannabis Inc revenue for the last quarter amounts to 38.01M USD, decreased -58.01

What is Aurora Cannabis Inc (ACB)'s earnings per share (EPS) for the last quarter?

Aurora Cannabis Inc. EPS for the last quarter amounts to -0.99 USD, increased 130.23

How many employees does Aurora Cannabis Inc (ACB). have?

Aurora Cannabis Inc (ACB) has 1028 emplpoyees as of June 18 2026.

What is Aurora Cannabis Inc (ACB) market cap?

Today ACB has the market capitalization of 180.87M USD.